| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
31,205 |
26,212 |
$6.76M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25,790 |
18,409 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,293 |
6,111 |
$164.74 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,055 |
2,339 |
$131.01 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,664 |
1,261 |
$100.12 |
| 81000 |
|
4,264 |
3,161 |
$24.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,433 |
1,068 |
$2.22 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
809 |
619 |
$0.53 |
| 3075F |
|
1,352 |
1,131 |
$0.00 |
| 3080F |
|
451 |
383 |
$0.00 |
| 82962 |
|
181 |
127 |
$0.00 |
| 3079F |
|
2,270 |
1,864 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
491 |
369 |
$0.00 |
| 3008F |
|
13,455 |
10,663 |
$0.00 |
| 3074F |
|
5,060 |
4,111 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
206 |
204 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
773 |
763 |
$0.00 |
| 93000 |
|
186 |
121 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$0.00 |
| 1125F |
|
22 |
13 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,394 |
1,762 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
122 |
103 |
$0.00 |
| 1160F |
|
616 |
341 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
221 |
163 |
$0.00 |
| 3078F |
|
4,810 |
3,901 |
$0.00 |
| 3077F |
|
842 |
634 |
$0.00 |
| 81025 |
|
590 |
519 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,128 |
1,716 |
$0.00 |
| 1159F |
|
498 |
278 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
233 |
232 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
37 |
26 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
62 |
38 |
$0.00 |